Skip to main content
Journal of Lipid Research logoLink to Journal of Lipid Research
. 2012 Jul;53(7):1390–1398. doi: 10.1194/jlr.D019711

Localization and imaging of gangliosides in mouse brain tissue sections by laserspray ionization inlet[S]

Alicia L Richards *, Christopher B Lietz *, James Wager-Miller †,§, Ken Mackie †,§, Sarah Trimpin *,1
PMCID: PMC3371251  PMID: 22262808

Abstract

A new ionization method for the analysis of fragile gangliosides without undesired fragmentation or salt adduction is presented. In laserspray ionization inlet (LSII), the matrix/analyte sample is ablated at atmospheric pressure, and ionization takes place in the ion transfer capillary of the mass spectrometer inlet by a process that is independent of a laser wavelength or voltage. The softness of LSII allows the identification of gangliosides up to GQ1 with negligible sialic acid loss. This is of importance to the field of MS imaging, as undesired fragmentation has made it difficult to accurately map the spatial distribution of fragile ganglioside lipids in tissue. Proof-of-principle structural characterization of endogenous gangliosides using MSn fragmentation of multiply charged negative ions on a LTQ Velos and subsequent imaging of the GD1 ganglioside is demonstrated. This is the first report of multiply charged negative ions using inlet ionization. We find that GD1 is detected at higher levels in the mouse cortex and hippocampus compared with the thalamus. In LSII with the laser aligned in transmission geometry relative to the inlet, images were obtained in approximately 60 min using an inexpensive nitrogen laser.

Keywords: glycosphingolipids, inlet ionization, imaging mass spectrometry


Gangliosides are a class of glycosphingolipids (GSL) composed of an oligosaccharide chain anchored to a hydrophobic ceramide base. They are identified by the presence of at least one sialic acid in their sugar chain (Fig. 1) (1, 2). Gangliosides are found in all eukaryotic cells, primarily as plasma-membrane constituents in which they can segregate into lipid rafts (3, 4). The central nervous system contains high concentrations of gangliosides that participate in cell-cell interactions and regulate cell proliferation (5), differentiation (6, 7), recognition (8) and signaling (9). In biological systems, gangliosides comprise a variety of related structures (10). Heterogeneity comes from their oligosaccharide content, linkage, and other modifications, and from variations of the ceramide moiety, including chain length and degree of unsaturation and hydroxylation (11). The structure of both the ceramide and oligosaccharide can vary with species and environment and can change with development (1214), aging (15, 16), and disease, making them important biomarkers (17, 18) of certain diseases, including Alzheimer's (19, 20), Tay-Sachs (1, 21, 22), and cancer (2325). Because ganglioside species may have only minor structural variations and may be present in low abundance, sensitive methods are required for their analysis for both identification of their structures and location within normal and diseased tissue.

Fig. 1.

Fig. 1.

Structures of ganglioside species analyzed. GM1 (one sialic acid), GD1a, GD1b, and GD3 (two sialic acids), GT1b (three sialic acids), and GQ1b (four sialic acids).

Although the sensitivity of mass spectrometry (MS) is ideal for profiling of gangliosides, the fragile glycosidic bond linking sialic acid to their oligosaccharide chain, especially with multiple sialic acids, breaks during vacuum matrix-assisted laser desorption/ionization (MALDI), complicating accurate identification of these gangliosides (2628). Dehydration and decarboxylation have also been reported (27). To compensate, derivitization of carboxylic acid has been used to stabilize sialic acid, making it less amenable to fragmentation (29, 30). Matrix selection has also been shown to affect fragmentation (3133). High-pressure, vibrationally cooled MALDI reduces in-source fragmentation but requires instrument modifications (10, 28, 34). “Softer” vacuum MALDI techniques have been used, such as infrared (IR)-MALDI, which allow the analysis of GD1 with negligible fragmentation or salt adduction (35, 36). Atmospheric pressure (AP)-MALDI decreases the fragmentation and matrix cluster formation common to vacuum MALDI, although sialic acid loss is present in more complex gangliosides (37). Electrospray ionization (ESI) provides soft ionization, but is limited to analyzing gangliosides in solution (38, 39).

Several methods are available to determine the distribution of gangliosides in tissue. Monoclonal antibodies can detect differences in the hydrophilic oligosaccharide chain on the cell surface but not in the fatty alcohol or N-acyl carbon chains embedded in the lipid bilayer (40). MALDI imaging MS is an effective technique for visualizing the distribution of metabolites (41, 42), lipids (4345), and proteins (46) in tissue, but MALDI imaging of gangliosides, as noted above, is limited because in-source or metastable fragmentation of polysialylated gangliosides results in the production of GM1, making differentiating the GM1 from fragment ions difficult and thus limiting the ability to assign the correct ganglioside species (3133, 4749). MALDI analysis and imaging of gangliosides containing multiple sialic acids is further complicated because these gangliosides form potassium and sodium adducts, reducing sensitivity and producing very complex mass spectra, which also adds difficulty in determining the correct ganglioside distribution (31). Despite these limitations, several groups have demonstrated the differential distribution of gangliosides in mouse brain tissue (3133, 48, 49), offering precedence for imaging of gangliosides using MALDI as a desorption/ionization method. Mono-sialylated gangliosides, including GM2 and GM3, have been imaged by MALDI without fragmentation or salt adduction (32, 50). Other surface methods, including desorption electrospray ionization (DESI), are applicable to imaging, but the achievable spatial resolution is lower than the spatial resolution commonly attainable with MALDI imaging (51).

Laserspray ionization inlet (LSII) is a novel method (supplementary Fig. I-A) that combines a soft, ESI-like ionization with the high spatial resolution surface sampling capabilities of MALDI. In LSII, solid-state matrix/analyte mixtures are laser ablated at AP into the heated inlet capillary of a mass spectrometer. With the assistance of thermal energy and vacuum, ions are created inside the inlet capillary as the analyte moves through the pressure gradient from AP to vacuum. The observed positively charged ions are highly charged, similar to ESI, and examples include peptides, proteins, and synthetic polymers (5255). LSII is a subset of matrix assisted inlet ionization (MAII; supplementary Fig. I-B), which operates independent of a voltage or a laser (56). MAII and LSII depend on the appropriate matrix (5759), similar to MALDI (6063), but do not require absorption at the laser wavelength employed. In LSII, the laser ablation only acts as the method to transfer a matrix/analyte sample into the inlet of the mass spectrometer, permitting the use of highly focused lasers to improve spatial resolution. Additionally, LSII often employs transmission geometry (TG) in which the laser is aligned 180° to the sample/orifice and ablates the analyte from the backside (supplementary Fig. I-C) (52, 6466). This technique offers further improvements to spatial resolution and high-throughput acquisitions (65, 66), as only a single laser shot is required to obtain a mass spectrum. This is especially important for imaging mass spectrometry, in which LSII has recently been developed by Richards et al. (65) to image phospholipids and sulfatides from mouse brain tissue using solvent-free sample preparation, inlet ionization (supplementary Fig. I) at 450°C, and detection of the singly charged negative ions. Here, we show MSn analysis and tissue imaging of fragile gangliosides producing multiply charged negative ions using LSII with inlet temperatures at 400°C or higher without the fragmentation or metal adduct formation common to MALDI.

MATERIALS AND METHODS

Materials

Matrixes 2,6-dihydroxyacetophenone (2,6-DHAP), 2,4,6-trihydroxyacetophenone (THAP), and 2,5-dihydroxybenzoic acid (2,5-DHB), and ganglioside standards from bovine brain GM1, GD1a, GD1b, and GT1b were purchased from Sigma Aldrich Inc. (St. Louis, MO). Ganglioside standards from bovine brain GD3 and GQ1b were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). 2,5-dihydroxyacetophenone (2,5-DHAP) matrix and solvents acetonitrile, ethanol, and methanol were purchased from Fisher Scientific Inc. (Pittsburgh, PA). Matrixes and ganglioside standards were used without further purification.

Ganglioside standard sample preparation

Ganglioside standards GM1 and GD1 were dissolved in methanol to 1 pmol μl−1. Standards GD3 and GT1b were dissolved in methanol to 5 pmol μl−1. Standard GQ1b was dissolved in methanol to 10 pmol μl−1. Saturated 2,5-DHAP, 5 mg ml−1 2,5-DHB, and 20 mg ml−1 2,4,6-THAP matrix solutions were prepared in acetonitrile-water (1:1; v/v). Saturated 2,6-DHAP matrix solution was prepared in ethanol-water (1:1; v/v) and in acetonitrile-water (1:1; v/v). For LSII MS analysis, 0.5 μl of ganglioside standard solution was spotted on to a glass microscopy slide (Gold Seal, Portsmouth, NH), followed by 1.5 μl of matrix solution. The ganglioside and matrix were then mixed on the glass slide while still wet. For MALDI MS analysis, ganglioside standards and matrix were premixed in a 1:1 v:v ratio. The dried droplet method (61) was used to spot 1 μl of the matrix/standard mixture onto the sample plate.

Tissue preparation

Animal care was in accordance with the US Public Health Service Policy on Humane Care and Use of Laboratory Animals. The mouse experimental studies were approved by the Institutional Animal Care and Use Committee of the University of Indiana, Bloomington. Mouse brain tissue was obtained from C57 B1/6 mice, 20 weeks old, that were euthanized with an overdose of isoflurane anesthesia and transcardially perfused with ice-cold 1× phosphate-buffered saline (150 mM NaCl, 100 mM NaH2PO4, pH 7.4) for 5 min to remove red blood cells. The brains were frozen at −22°C and sliced into 10 μm thick sections in sequence using a Leica CM1850 cryostat (Leica Microsystems Inc., Bannockburn, IL). The tissue sections were placed on prechilled glass microscopy slides that were precoated with 2,5-DHB matrix. 2,5-DHB was preground in a glass vial containing 1.3 mm chrome beads for 30 min at 15 Hz using a TissueLyser II ball mill device (Qiagen, Valencia, CA). The preground matrix was then applied to the glass slide using a previously published procedure (67). Briefly, 2,5-DHB was placed in the bottom compartment of the TissueBox with approximately 30 beads. The glass slide was separated from the matrix by 5 μm mesh. The TissueBox was placed in the TissueLyser II, where the movement of beads forced matrix through the mesh and onto the slide. The precoated slides were briefly warmed with a finger from behind to allow sections to relax and attach. To avoid water condensation, the tissue was stored at −20°C and transported under dry ice in an airtight, desiccant-containing box where it were kept until use. Before imaging, 300 mg of 2,5-DHAP was dissolved in 9 ml of acetonitrile-water (1:1; v/v) and applied to the tissue using an artistic airbrush.

Mass spectrometry and data processing

LSII-MS, MSn, and imaging experiments were performed on a Thermo Fisher Velos LTQ (Thermo Fisher Scientific, Bremen, Germany) linear ion trap mass spectrometer. The instrument was operated in negative ion mode using a mass range mass-to-charge (m/z) 500–2400, depending on the molecular weight of the ganglioside. Similar to previous work (65), the source housing was removed and the interlocks were overridden to allow unobstructed access to the ion entrance orifice. A 337 nm nitrogen laser (Newport Corporation, Irvine, CA; VSL-337ND-S) beam aligned 180° from the entrance of the mass spectrometer and focused on the ion transfer capillary using a 102 mm focal length lens (CVI Melles Griot, Albuquerque, NM) was used to ablate the sample directly into the mass spectrometer. The laser fluence per pulse was approximately 0.5–1.0 J cm−2.

For LSII analysis of ganglioside standards, samples were placed approximately 1–2 mm from the mass spectrometer vacuum entrance (inlet) and moved manually through the laser beam. Each spectrum represents one laser shot. The ion trap fill time was set at 50 msec. The sheath gas flow rate, auxiliary gas flow rate, and sweep gas flow rate were all set to 0 (arbitrary units). Spray voltage was set to 0 kV. The capillary temperature was 400 to 450°C when using 2,5-DHB. A capillary temperature of 400°C was used with 2,5-DHAP matrix. Peak assignments and structural information were obtained using collision-induced dissociation (CID) LSII MSn. For ganglioside standards, an isotopic width of 0.7 and collision energies of 25–33 eV were used. For tissue, an isotopic width of 1.0 and a collision energy of 40 eV were used.

For imaging experiments, the glass slide mounted with mouse brain tissue was attached to a computer-controlled xyz stage (Newmark Systems, Mission Viejo, CA) using a custom-made sample holder and moved through the laser beam in TG mode. Lanes were spaced at 100 μm intervals, and each lane was 10.2 mm long. The tissue was moved through the laser at a speed of 100 μm sec−1. The laser was fired only once at each position on the tissue; each pixel of the image represents a single laser shot. The ion trap fill time was set to 125 msec. Gangliosides were detected using 2,5-DHAP matrix with inlet temperatures of at least 400°C. Tissue images were created using BioMAP 3.7.5.6 (Novartis Institutes for BioMedical Research, Basel, Switzerland). Thermo XCalibur .RAW files were converted to .IMG files using customized imaging software.

Intermediate pressure (0.16 Torr) MALDI MS was performed on a SYNAPT G2 mass spectrometer (Manchester, UK) equipped with a Nd:YAG laser (355 nm). The instrument was operated in negative ion sensitivity mode. A laser fluence of 250–300 (arbitrary units) and a 200 Hz firing rate were used. The sensitivity mode settings were 0 V for the sample plate, 10 V “extraction,” 10 V “hexapole bias,” and 5 V “aperture 0.” Approximately 20 laser shots were summed for each spectrum. LSII-MS was performed on the SYNAPT G2 by converting the nano-ESI source to a LSII source according to published procedure (5459, 68) using the 337 nm nitrogen laser employed for LSII-MS on the LTQ Velos.

RESULTS AND DISCUSSION

Method development of LSII-MS and MSn using ganglioside standards

Standard gangliosides were used to establish and optimize the LSII MS, MSn, and imaging conditions for detection of gangliosides directly from tissue. Matrixes, 2,5-DHB and 2,5-DHAP, were tested on purchased samples of GM1, GD1a and GD1b, GD3, GT1b, and GQ1b. As previously reported, the temperature of the ion entrance orifice to the mass spectrometer is an important LSII parameter in both positive and negative ion mode detection (65). Ion abundance in LSII is increased by heating the ion transfer capillary (53, 6870). Using 2,5-DHB on a LTQ Velos mass spectrometer, GD1 could only be analyzed at capillary temperatures between 400°C and the maximum setting of 450°C in the negative ion mode. The negatively charged ions at m/z 1836.8 (d18:1-18:0) and 1864.8 (d20:1-18:0) were identified as [GD1-H]- (Fig. 2A). Low abundance fragment ions corresponding to the loss of one sialic acid are observed at m/z 1544.9 and 1572.9. To confirm the negligible fragmentation with LSII, a mass spectrum of GD1 was acquired from m/z 150 to 2000. An inset of the lower mass region (supplementary Fig. II) reveals predominantly matrix clusters. The sialic acid fragment, which would appear at m/z 290, is not observed. At capillary temperatures below 400°C, only matrix aggregates are present, and GD1 is not detected (supplementary Fig. III). The more complex GT1b and GQ1b, which contain up to four sialic acids, could not be analyzed using 2,5-DHB. We speculate this is due to the high temperature requirements of 2,5-DHB when used as a LSII matrix (53, 65, 70, 71).

Fig. 2.

Fig. 2.

Negative mode MS analysis of GD1 ganglioside. Mass spectra: (A) LSII with 2,5-DHB matrix; (B) LSII with 2,5-DHAP matrix; and (C) MALDI with 2,5-DHB matrix.

A unique feature of LSII is the ability to selectively produce multiply charged ions or singly charged ions depending on the sample preparation and voltage application (52, 55, 72). 2,5-DHB produces only singly charged negative ions of GD1 (Fig. 2A), whereas 2,5-DHAP primarily produces doubly charged negative ions (Figs. 2B, 3). Interestingly, 2,5-DHAP produces negligible or no fragment ions. The absence of fragmentation with 2,5-DHAP matrix may be the result of lower thermal requirements in LSII (53, 72). We are currently investigating mechanistic arguments that may assist in providing an explanation for these observations (58, 59). The mass spectrum of purchased GD1 using 2,5-DHAP as matrix is shown in Fig. 2B obtained using 400°C inlet capillary temperature. However, molecular ions were observed between 100°C and 450°C for GD1 using this matrix (supplementary Fig. IV). The signals at m/z 917.4 and m/z 932.0 represent the doubly charged intact deprotonated GD1 (d18:1-18:0) and GD1 (d20:1-18:0), respectively. Singly deprotonated ions were also detected for GD1 at m/z 1836.9 (d18:1-18:0) and 1865.0 (d20:1-18:0). Further, although GD1 is present as the doubly deprotonated ion, the signals corresponding to sialic acid loss occur as low abundant singly deprotonated ions at m/z 1,545.5 and 1,573.5. The sialic acid fragment at m/z 290 is not present (supplementary Fig. V), again confirming minimal fragmentation with LSII.

For comparison, the commercial intermediate pressure MALDI source on the SYNAPT G2 was used for the analyses of a number of ganglioside standards. Fig. 2C shows the MALDI results for GD1 using 2,5-DHB as a matrix. The intact singly deprotonated ions were detected at m/z 1836.06 and 1864.06, but they are accompanied by adduction and fragmentation peaks, most of which were in higher abundance than the deprotonated intact ion. Salt adduction is present at m/z 1859.06, 1874.04, and 1886.04. The dehydrated ions at m/z 1818.02 and 1847.05 tentatively identified as [GD1(d18:1-18:0)-H2O-H] and [GD1(d20:1-18:0)-H2O-H], respectively, are more abundant than the parent ions. The dominant ions at m/z 1544.92 and 1572.96 arise from sialic acid loss, and they appear at similar m/z values as those obtained for MALDI of GM1 (supplementary Fig. VI). MALDI acquisitions were also obtained with 2,5-DHAP as the matrix, and the resulting mass spectra contained identical m/z signals to those obtained with 2,5-DHB but with overall lower abundances (supplementary Fig. VII-A). To demonstrate that the observed fragmentation was a consequence of MALDI and not simply caused by instrumentation differences relative to the LTQ Velos, supplementary Fig. VII-B shows an LSII acquisition of GD1 with 2,5-DHAP on the SYNAPT G2 using the nano-ESI source converted to a LSII source (54, 55, 5759, 68). Abundant [M-2H]2− ions are observed without adduction or fragmentation.

The soft LSII analysis of gangliosides other than GD1 is demonstrated in Fig. 3. In Fig. 3A, the intact singly deprotonated GM1 ions at m/z 1545.1 (d18:1-18:0) and m/z 1573.1 (d20:1-18:0) were the only abundant signals. GD3 analysis in Fig. 3B resulted in intact singly deprotonated ions at m/z 1442.5 (d16:1-18:0), 1470.8 (d18:1-18:0), and 1498.8 (d20:1-18:0), as well as singly and double acetylated GD3 gangliosides at m/z 1512.8, 1540.8, and 1554.8, respectively. The corresponding doubly deprotonated ions were observed at m/z 720.9, 734.9, 748.9, 755.9, 769.9, and 777.0. In Fig. 3C, analysis of the trisialylated GT1b resulted in intact doubly deprotonated ions at m/z 1063.0 (d18:1-18:0) and 1077.0 (d20:1-18:0). Additionally, sodium and potassium replacement of an acidic hydrogen was detected at m/z 1088.0 and 1095.9. Finally, the analysis of GQ1b, a ganglioside with four sialic acids, produced the intact doubly deprotonated ions at m/z 1208.5 (d18:1-18:0) and m/z 1222.4 (d20:1-18:0). The species with sodium and potassium replacing and acidic hydrogen were observed at m/z 1227.4, 1233.4, and 1241.4, respectively. A low abundance, triply deprotonated signal was present at m/z 814.9. According to the supplier information, GT1b and GQ1b are provided as salts (73), and it is our belief that the metal cation adduction was not from the LSII process but from the extract itself, as no other adduction is present.

Fig. 3.

Fig. 3.

Negative mode LSII MS analysis of gangliosides with 2,5-DHAP matrix. Mass spectra of (A) GM1; (B) GD3; (C) GT1b; and (D) GQ1b.

Astonishing differences were observed between LSII detecting intact parent ions in high abundance (Fig. 2A, B) and MALDI detecting a notable degree of fragment ions (Fig. 2C). MALDI, using the matrix 2,5-DHB and the commercial intermediate pressure source of the SYNAPT G2, of GD3 (supplementary Fig. VIII), GT1b (supplementary Fig. IX), and GQ1 (supplementary Fig. X) produced intact parent ions, along with extensive fragmentation and adduction patterns. Only GM1 (supplementary Fig. VI) did not display fragmentation in MALDI. As expected, the desialylated lipids appeared at the same m/z as the MALDI signal from GM1. MALDI fragmentation caused the intensity of GM1 to be artificially high and hindered any attempts at relative or spatially distributed quantification of this lipid. 2,6-DHAP, which has been used as a matrix for MALDI analysis of gangliosides (32, 33), and 2,4,6-THAP were also tested for LSII analysis of gangliosides, but they yielded poor results (supplementary Fig. XI). Some fragmentation was observed with LSII but at intensity levels greater than an order of magnitude less than the parent ions. We conclude that the “softness” of LSII circumvents fragmentation issues similar to ESI.

To assess the potential for structural assignments of gangliosides, LSII CID was performed. Fragments were assigned according to the convention set by Domon and Costello (74) and Ann and Adams (75). Supplementary Fig. XII shows the MS2 to MS6 spectra of the doubly deprotonated GD1b ion at m/z 917.7 with an isolation window of 0.7 and collision energy of 25–33 eV. GD1 exists as a mixture of structural isomers, GD1a and GD1b, which differ in the location of their sialic acids (Fig. 1). CID can differentiate between the isomers based on fragmentation patterns that are similar to ESI from these lipids from solution (76, 77). For example, in the MS2 to MS4 spectra, major signals came from the sequential loss of oligosaccharide chain moieties at m/z 1544.8, 1253.7, 1091.9, 888.7, 726.6, and 563.2. The abundant signal at m/z 581.2 was indicative of the GD1b isomer, as it corresponds to the loss of two attached sialic acids not present in the GD1a isomer. MS5 and MS6 scans were able to reveal information about the ceramide chain.

LSII imaging of gangliosides was examined using a model system of GM1 and GD1 ganglioside standards (supplementary Fig. XIII) that were mixed with 2,5-DHAP matrix and spotted side by side on a glass slide, with GM1 on the left and GD1 on the right. The spots were imaged using LSII with the laser aligned in TG using the homebuilt source and by MALDI with the laser aligned in reflection geometry using a commercial intermediate pressure MALDI source on the SYNAPT G2 mass spectrometer. The images were created for m/z 1572.8, corresponding to GM1 (d20:1-18:0) and also the undesired fragment ion of GD1. In the LSII image, m/z 1572.8 is located almost exclusively on the sample spot containing the GM1 standard (supplementary Fig. XIII-B, left side of the images), suggesting usefulness for accurate ganglioside imaging. With MALDI, m/z 1572.8 appears on both sides of the image, although GM1 was only spotted on the left side (supplementary Fig. XIII-A), making the distinction between GM1 and the fragment of GD1 difficult. The performance of 2,5-DHAP matrix in negative mode has been noted (37, 62, 65), but because it sublimes in vacuum MALDI (78), its use in imaging has been restricted. The lack of fragmentation and sodiation in LSII using this and other matrixes relative to MALDI analysis of purchased standards provides a basis for tissue-bound ganglioside analysis.

Structural characterization and imaging of endogenous gangliosides directly from mouse brain tissue using LSII-MS and MSn

In the initial structural characterization and imaging studies of endogenous gangliosides directly from tissue, 2,5-DHAP was used, as less fragmentation is observed with this matrix compared with 2,5-DHB. Because ablation is at AP with LSII, matrix sublimation is not an issue. A single LSII acquisition obtained from one laser shot penetrating the mouse brain tissue in TG shows many different lipids in the mass spectrum (Fig. 4A). Abundant signals at m/z 700.5, 766.6, 790.6, and 862.7 were assigned to various phospholipids and sulfatides. Doubly charged GD1 ions were detected at m/z 917.5 and 931.5. The isotope distributions were consistent with a doubly charged ion as shown for the m/z 917.5 ion in Fig. 4B. Fig. 4C shows low abundant signals at m/z 1544.8 and 1572.8 that were assigned to the singly charged [GM1-H] ions.

Fig. 4.

Fig. 4.

Negative mode LSII analysis of gangliosides in mouse brain tissue. (A) Single laser shot mass spectrum from mouse brain tissue with 2,5-DHAP matrix. (B) Inset of the doubly deprotonated GD1 ganglioside at m/z 917.5 (d18:1/C18:0). (C) Inset shows GM1 ganglioside present in low abundance, suggesting negligible fragmentation.

Although GD1 is the most abundant ganglioside in the brain (79, 80), in MALDI mass spectra of tissue, the signal corresponding to [GM1-H] is frequently the most abundant ganglioside signal, possibly due to GD1 fragmentation. With LSII, the GM1 species is present in much lower abundance than the GD1 species (Fig. 4), suggesting that the distribution of tissue gangliosides revealed by LSII more likely reflects their authentic distribution. Although LSII is able to reduce undesired in-source fragmentation, lower abundant gangliosides, including the O-acetylated species and the GQ1 species imaged by Colsch et al., are yet not detected in tissue (32). This may be the result of selective ionization in LSII using 2,5-DHAP or may be because the sensitivity of LSII, similar to AP-MALDI, is currently lower than vacuum MALDI.

LSII CID MSn can be used to confirm the ganglioside structures ablated directly from mouse brain tissue. Because of the abundant multiply charged ions produced by LSII using 2,5-DHAP, linkage information can be obtained from gangliosides from tissue without employing extraction techniques. For example, LSII MS2 was used to identify the GD1b isomer directly from tissue (supplementary Fig. XIV-A). The doubly charged molecular ion at m/z 917.5 selected for CID fragmentation shows signals at m/z 1544.5, 1253.5, 1091.8, 888.8, and, in low abundance, 726.6 and 563.5, which correspond to the loss of successive sugar groups from the oligosaccharide chain and are in agreement with the results obtained from the GD1b standard (supplementary Fig. XII-A). The characteristic [sialic acid-H] fragment is present at m/z 290. These signals are in agreement with CID of GD1 using ESI (32, 8183). Several fragments identify the GD1b isomer, particularly m/z 581.3, which corresponds to the loss of two attached sialic acids. Lower intensity fragment ions, including m/z 1382.9, the loss of the two end group sugars (sialic acid and galactose), and m/z 1161.8, the loss of the end group sialic acid, and galactose and the attached GalNAc, also suggest the GD1b isomer. For further confirmation, MSn was compared against results obtained for the GD1b standard (supplementary Fig. XII). Not only were the tissue-bound lipids identified by identical MS/MS fragmentation compared with purchased standards, single laser ablation events determined the existence of the GD1b isomer based on the presence of signals corresponding to a sialic acid dimer, the end group sugars, and the GalNac group (82). For comparison, CID of GD1a from tissue is included in supplementary Fig. XIV-B. Targeted tissue analysis is complicated by isobaric and isomeric species that are often remedied with FT-ICR-MS and CID analysis (84, 85). However, LSII can detect gangliosides with enough abundance to confirm identification using MSn with less expensive and simpler mass analyzers as is shown here for the linear ion trap on the LTQ-Velos.

In a proof-of-principle imaging study (supplementary Fig. I-C), LSII was used to image GD1 species directly from mouse brain tissue. Because of the low resolution of the LTQ Velos and to ensure only the doubly deprotonated GD1 species were imaged, imaging experiments were conducted in zoom mode to provide higher mass resolution. 2,5-DHAP was used as matrix and applied on top of the tissue using the spray coating approach (86). Improved results were obtained by combining spray coating with the precoated approach (64, 66, 87), in which the matrix was also placed below the tissue. The enhanced ionization is rationalized by the extraction of lipids into the matrix from both surfaces of the 10 μm thick tissue section. The laser aligned in TG ablated both matrix layers for ionization. As is the case with MALDI spray coating approaches (88, 89), the slightly wet matrix may assist in extracting the analyte from the ablated tissue into the matrix. Matrixes such as 2,5-DHB and 2,5-DHAP showed usefulness for precoating the mouse brain tissue. Images of [GD1-2H]2− are shown in Fig. 5 for m/z 917.5 (d18:1-18:0) and m/z 931.5 (d20:1-18:0). In the tissue imaging experiments, each pixel of the image represents a single laser shot. The single shot per pixel allows high spatial resolution images (∼20 μm) obtained in approximately 1 h. Although both species of GD1 are located throughout the brain, they are more abundant in the hippocampus and cortex than in the underlying thalamus. The distribution of the two forms differed slightly, with GD1 at m/z 917.5 (d18:1-18:0) present in higher abundance than m/z 931.5 (d20:1-18:0), as also observed in Fig. 4.

Fig. 5.

Fig. 5.

TG LSII imaging mass spectrometry of (A) section from the Allen Brain Atlas (93) corresponding approximately to the experimental section. The scale bar is 1001 μm, upper-right corner. The red highlighted area corresponds approximately to the molecular layer. (B) Experimental section of a 10 μm thick mouse brain slice. (C) [M-2H]2− ion images of GD1 at (C.1) m/z 917.5 and (C.2) m/z 931.5.

Negative ion MSn successfully characterized fragile ganglioside lipids directly from mouse brain tissue aided by the “softness” of ionization using LSII and the propensity to form multiply charged ions. The potential for imaging these lipids in mouse brain tissue is demonstrated for doubly charged negative ions for GD1. The near absence of fragmentation of fragile gangliosides and the lack of metal adduct ions when using LSII aids analyses directly from tissue in which time-consuming separation methods are not possible. This is in contrast to MALDI analyses of these compounds in which special conditions are necessary to reduce fragmentation and adduction. Multiply charged ions produced by ESI can be detected with high sensitivity (90). Our hypothesis is that with proper thermal and vacuum conditions, equivalent or better sensitivities can be achieved in inlet ionization, as is supported by recent work using solvent-assisted inlet ionization (supplementary Fig. I-D) of 0.7 ng of protein digest on column (91). We further hypothesize that shorter acquisition times will simplify convoluted mass spectral data relative to sample complexity and charge state distributions associated with the direct analysis of tissue material (66) and that deconvolution programs will assist in the interpretation of LSII ions similar to those used in ESI (92). Besides addressing pressing needs for enhanced desolvation of the matrix in inlet ionization through instrument modifications, current research aimed at imaging gangliosides includes the search for improved matrix materials for ease in desolvation/ionization at lower inlet temperatures; improving sample preparation techniques, particularly matrix preparation and application, to visualize lower abundance gangliosides such as GT1 and GQ1 from tissue while enhancing sensitivity and spatial resolution; shortening analyses time (<10 min for one mouse brain tissue section) (57); and enhancing dynamic range by expanding applications to LSII-ion mobility spectrometry-MS (54, 55, 59, 68) and MSn imaging for the differentiation of ganglioside isomers.

Supplementary Material

Supplemental Data

Footnotes

Abbreviations:

AP
atmospheric pressure
CID
collision-induced dissociation
DESI
desorption electrospray ionization
2,5-DHAP
2,5-dihydroxyacetophenone
2,5-DHB
2,5-dihydroxybenzoic acid
GSL
glycosphingolipid
IMS
ion mobility spectrometry
IR
infrared
LSII
laserspray ionization inlet
MAII
matrix-assisted inlet ionization
TG
transmission geometry
THAP
trihydroxyacetophenone

This work was supported by National Science Foundation CAREER 0955975, American Society for Mass Spectrometry (ASMS) Research Award (Waters Corporation), DuPont Young Professor Award (to S.T.), and National Institutes of Health Grants DA-11322 and DA-21696 (to K.M.). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health.

[S]

The online version of this article (available at http://www.jlr.org) contains supplementary data in the form of 14 figures.

REFERENCES

  • 1.Kolter T., Sandhoff K. 2006. Sphingolipid metabolism diseases. Biochim. Biophys. Acta. 1758: 2057–2079 [DOI] [PubMed] [Google Scholar]
  • 2.Fishman P. H., Brady R. O. 1976. Biosynthesis and function of gangliosides. Science. 194: 906–915 [DOI] [PubMed] [Google Scholar]
  • 3.Brown D. A., London E. 2000. Structure and function of sphingolipid and cholesterol-rich membrane rafts. J. Biol. Chem. 275: 17221–17224 [DOI] [PubMed] [Google Scholar]
  • 4.Simons K., Toomre D. 2000. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 1: 31–39 [DOI] [PubMed] [Google Scholar]
  • 5.Mirkin B. L., Clark S. H., Zhang C. 2002. Inhibition of human neuroblastoma cell proliferation and EGF receptor phosphorylation by gangliosides GM1, GM3, GD1a and GT1b. Cell Prolif. 35: 105–115 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Nojiri H., Takaku F., Terui Y., Miura Y., Saito M. 1986. Ganglioside GM3: an acidic membrane component that increases during macrophage-like cell differentiation can induce monocytic differentiation of human myeloid and monocytoid leukemic cell lines HL-60 and U937. Proc. Natl. Acad. Sci. USA. 83: 782–786 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Facci L., Skaper S. D., Favaron M., Leon A. 1988. A role for gangliosides in astroglial cell differentiation in vitro. J. Cell Biol. 106: 821–828 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Lopez P. H., Schnaar R. L. 2009. Gangliosides in cell recognition and membrane protein regulation. Curr. Opin. Struct. Biol. 19: 549–557 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Hakomori S., Igarashi Y. 1995. Functional role of glycosphingolipids in cell recognition and cell signaling. J. Biochem. 118: 1091–1103 [DOI] [PubMed] [Google Scholar]
  • 10.O'Connor P. B., Mirgorodskaya E., Costello C. E. 2002. High-pressure matrix-assisted laser desorption/ionization Fourier transform mass spectrometry for minimization of ganglioside fragmentation. J. Am. Soc. Mass Spectrom. 13: 402–407 [DOI] [PubMed] [Google Scholar]
  • 11.Kolter P., Prica R. L., Sandhoff K. 2002. Combinatorial ganglioside biosynthesis. J. Biol. Chem. 277: 25859–25862 [DOI] [PubMed] [Google Scholar]
  • 12.Yu R. K., Nakatani Y., Yanagisawa M. 2009. The role of glycosphingolipid metabolism in the developing brain. J. Lipid Res. 50: S440–S445 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Svennerholm L., Rynmark B. M., Vilbergsson G., Fredman P., Gotfries J., Manson J. E., Percy A. 1991. Gangliosides in human fetal brain. J. Neurochem. 56: 1763–1768 [DOI] [PubMed] [Google Scholar]
  • 14.Yu R. K., Macala I. J., Taki T., Weinfield H. M., Yu F. S. 1988. Developmental changes in ganglioside composition and synthesis in embryonic rat brain. J. Neurochem. 50: 1825–1829 [DOI] [PubMed] [Google Scholar]
  • 15.Palestini P., Sonnino S., Tettamanti G. 1991. Lack of the ganglioside molecular species containing the C20-long-chain bases in human, rat, mouse, rabbit, cat, dog, and chicken brains during prenatal life. J. Neurochem. 56: 2048–2050 [DOI] [PubMed] [Google Scholar]
  • 16.Kracun I. I., Rosner H., Drnovsek V., Vukelic Z., C´osovic C., Trbojevic-Cepe M., Kubat M. 1992. Gangliosides in the human brain developing and aging. Neurochem. Int. 20: 421–431 [DOI] [PubMed] [Google Scholar]
  • 17.Svennerholm L., Boström K., Fredman P., Mansson J-E., Rosengren B., Rynmark B-M. 1989. Human brain gangliosides: developmental changes from early fetal stage to advanced age. Biochim. Biophys. Acta. 2: 109–117 [DOI] [PubMed] [Google Scholar]
  • 18.Vanier M. T., Holm M., Öhman R., Svennerholm L. 1971. Developmental profiles of gangliosides in human and rat brain. J. Neurochem. 18: 581–592 [DOI] [PubMed] [Google Scholar]
  • 19.Ariga T., McDonald M. P., Yu R. K. 2008. Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease—a review. J. Lipid Res. 49: 1157–1175 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Yanagisawa K., Odaka A., Suzuki N., Ihara Y. M. 1995. GM1 ganglioside-bound amyloid β-protein (Aβ): a possible form of preamyloid in Alzheimer's disease. Nat. Med. 1: 1062–1066 [DOI] [PubMed] [Google Scholar]
  • 21.Yamanaka S., Johnson M. D., Grinberg A., Westphal H., Crawley J. N., Taniike M., Suzuki K., Proia R. L. 1994. Targeted disruption of the hexa gene results in mice with biochemical and pathologic features of Tay-Sachs disease. Proc. Natl. Acad. Sci. USA. 91: 9975–9979 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Mahuran D. J. 1999. Biochemical consequences of mutation causing the GM2 gangliosides. Biochim. Biophys. Acta. 1455: 105–138 [DOI] [PubMed] [Google Scholar]
  • 23.Hakomari S. 1996. Tumor malignancy defined by aberrant glycosylation and sphingo(glycol)lipid metabolism. Cancer Res. 56: 5309–5318 [PubMed] [Google Scholar]
  • 24.Hakomari S. I. 1981. Glycosphingolipids in cellular interaction, differentiation and oncogenesis. Annu. Rev. Biochem. 50: 733–764 [DOI] [PubMed] [Google Scholar]
  • 25.Lang Z., Guerrera M., Li R., Ladisch R. 2001. Ganglioside GD1a enhances VEGF-induced endothelial cell proliferation and migration. Biochem. Biophys. Res. Commun. 282: 1031–1037 [DOI] [PubMed] [Google Scholar]
  • 26.Harvey D. J. 1996. Matrix-assisted laser desorption/ionization mass spectrometry of oligosaccharides and glycoconjugates. J. Chromatogr. A. 720: 429–446 [DOI] [PubMed] [Google Scholar]
  • 27.Sugiyama E., Hara A., Uemara K., Taketomi T. 1997. Application of matrix-assisted laser desorption ionization time-of-flight mass spectrometry with delayed ion extraction to ganglioside analyses. Glycobiology. 7: 719–724 [DOI] [PubMed] [Google Scholar]
  • 28.Ivelva V. B., Sapp L. M., O'Conner P. B., Costello C. E. 2005. Ganglioside analysis by thin-layer chromatography matrix-assisted laser desorption/ionization orthogonal time-of-flight mass spectrometry. J. Am. Soc. Mass Spectrom. 16: 1552–1560 [DOI] [PubMed] [Google Scholar]
  • 29.Sekiya S., Wada Y., Tanaka K. 2005. Derivitization for stabilizing sialic acids in MALDI-MS. Anal. Chem. 77: 4962–4968 [DOI] [PubMed] [Google Scholar]
  • 30.Zarei M., Bindila L., Souady J., Dreisewerd K., Berkenkamp S., Müthing J., Peter-Katalinic´ J. 2008. A sialylation study of mouse brain gangliosides by MALDI a-TOF and o-TOF mass spectrometry. J. Mass Spectrom. 43: 716–725 [DOI] [PubMed] [Google Scholar]
  • 31.Chan K., Lanthier P., Liu X., Sandhu J. K., Stanimirovic D., Li J. 2009. MALDI mass spectrometry imaging of gangliosides in mouse brain using ionic liquid matrix. Anal. Chim. Acta. 639: 57–61 [DOI] [PubMed] [Google Scholar]
  • 32.Colsch B., Jackson S. N., Dutta S., Woods A. S. 2011. Molecular microscopy of brain gangliosides: illustrating their distribution in hippocampal cell layers. ACS Chem. Neurosci. 2: 213–222 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Colsch B., Woods A. S. 2010. Localization and imaging of sialylated glycosphingolipids in brain tissue sections by MALDI mass spectrometry. Glycobiology. 21: 661–667 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Ivelva V. B., Elkin Y. N., Budnik B. A., Moyer S. C., O'Connor P. B., Costello C. E. 2004. Coupling thin-layer chromatography with vibrational cooling matrix-assisted laser desorption/ionization Fourier transform mass spectrometry for the analysis of ganglioside mixtures. Anal. Chem. 76: 6484–6491 [DOI] [PubMed] [Google Scholar]
  • 35.Tajiri M., Takeuchi T., Wada Y. 2009. Distinct features of matrix-assisted 6 μm infrared laser desorption/ionization mass spectrometry in biomolecular analysis. Anal. Chem. 81: 6750–6755 [DOI] [PubMed] [Google Scholar]
  • 36.Tajiri M., Wada Y. 2010. Infrared matrix-assisted laser desorption/ionization mass spectrometry for quantification of glycosaminoglycans and gangliosides. Int. J. Mass Spectrom. 305: 164–169 [Google Scholar]
  • 37.Zhang J., LaMote L., Dodds E. D., Lebrilla C. B. 2005. Atmospheric pressure MALDI Fourier transform mass spectrometry of labile oligosaccharides. Anal. Chem. 77: 4429–4438 [DOI] [PubMed] [Google Scholar]
  • 38.Fenn J. B., Mann M., Meng C. K., Wong S. F., Whitehouse C. M. 1989. Electrospray ionization for mass spectrometry of large biomolecules. Science. 246: 64–71 [DOI] [PubMed] [Google Scholar]
  • 39.Zamfir A., Vukelic Z., Bindila L., Peter-Katalinic J., Almeida R., Sterling A., Allen M. 2004. Fully automated chip-based nanoelectrospray tandem mass spectrometry of gangliosides from human cerebellum. J. Am. Soc. Mass Spectrom. 15: 1649–1657 [DOI] [PubMed] [Google Scholar]
  • 40.Kotani M., Kawashima I., Ozawa H., Terashima T., Tai T. 1993. Differential distribution of major gangliosides in rat central nervous system detected by specific monoclonal antibodies. Glycobiology. 3: 137–146 [DOI] [PubMed] [Google Scholar]
  • 41.Stoeckli M., Staab D., Schweitzer A. 2007. Compound and metabolite distribution measured by MALDI mass spectrometric imaging in whole-body tissue sections. Int. J. Mass Spectrom. 260: 195–202 [Google Scholar]
  • 42.Hsieh Y., Casale R., Fukuda E., Chen J. W., Knemeyer I., Wingate J., Morrison R., Korfmacher W. 2006. Matrix-assisted laser desorption/ionization imaging mass spectrometry for direct measurement of clozapine in rat brain tissue. Rapid Commun. Mass Spectrom. 20: 965–972 [DOI] [PubMed] [Google Scholar]
  • 43.Hankin J. A., Farias S. E., Barkley R., Heidenreich K., Frey L. C., Hamazaki K., Kim H. Y., Murphy R. C. 2011. MALDI mass spectrometric imaging of lipids in rat brain injury models. J. Am. Soc. Mass Spectrom. 22: 1014–1021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Spraggins J. M., Caprioli R. 2011. High-speed MALDI-TOF imaging mass spectrometry: rapid ion image acquisition and considerations for next generation instrumentation. J. Am. Soc. Mass Spectrom. 22: 1022–1031 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Jackson S. N., Ugarov M., Egan T., Post J. D., Langlais D., Schultz J. A., Woods A. S. 2007. MALDI-ion mobility-TOFMS imaging of lipids in rat brain tissue. J. Mass Spectrom. 42: 1093–1098 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Van Remoortere A., van Zeijl R. J. M., van den Oever N., Franck J., Longuespée R., Wisztorski M., Salzet M. 2010. MALDI imaging and profiling MS of higher mass proteins from tissue. J. Am. Soc. Mass Spectrom. 21: 1922–1929 [DOI] [PubMed] [Google Scholar]
  • 47.Jackson S. N., Wang H. Y., Woods A. S. 2005. Direct profiling of lipid distribution in brain tissue using MALDI-TOFMS. Anal. Chem. 77: 4523–4527 [DOI] [PubMed] [Google Scholar]
  • 48.Sugiyura Y., Shimma S., Konishi Y., Yamada M. K., Setou M. 2008. Imaging mass spectrometry technology and application on ganglioside study; visualization of age-dependent accumulation of C20-ganglioside molecular species in the mouse hippocampus. PLoS ONE. 3: e3232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Whitehead S. N., Chan K. N. H., Gangaraju S., Slinn J., Li J., Hou S. T. 2011. Imaging mass spectrometry detection of gangliosides species in the mouse brain following transient focal cerebral ischemia and long-term recovery. PLoS ONE. 6: e20808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Chen Y., Allegood J., Liu Y., Wang E., Cachon-Gonzalez B., Cox T. M., Merrill A. H., Jr., Sullards M. C. 2008. Imaging MALDI mass spectrometry using an oscillating capillary nebulizer matrix coating system and its application to analysis of lipids in brain from a mouse model of tay-sachs/sandhoff disease. Anal. Chem. 80: 2780–2788 [DOI] [PubMed] [Google Scholar]
  • 51.Wiseman J. M., Ifa D. R., Zhu Y., Kissinger C. B., Manicke N. E., Kissinger P. T., Cooks R. G. 2008. Desorption electrospray ionization mass spectrometry: Imaging drugs and metabolites in tissue. Proc. Natl. Acad. Sci. USA. 105: 18120–18125 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Trimpin S., Inutan E. D., Herath T. N., McEwen C. N. 2010. A matrix-assisted laser desorption/ionization method for selectively producing either singly or multiply charged molecular ions. Anal. Chem. 82: 11–15 [DOI] [PubMed] [Google Scholar]
  • 53.Trimpin S., Inutan E. D., Herath T. N., McEwen C. N. 2010. Laserspray ionization, a new atmospheric pressure MALDI method for producing highly charged gas-phase ions of peptides and proteins directly from solid solutions. Mol. Cell. Proteomics. 9: 362–367 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Inutan E. D., Trimpin S. 2010. Laserspray ionization-ion mobility spectrometry-mass spectrometry: baseline separation of isomeric amyloids without the use of solvents desorbed and ionized directly from a surface. J. Proteome Res. 9: 6077–6081 [DOI] [PubMed] [Google Scholar]
  • 55.Wang B., Lietz C. B., Inutan E. D., Leach S. M., Trimpin S. 2011. Laserspray ionization ion mobility mass spectrometry mass spectrometry: a total solvent-free analysis approach at atmospheric pressure. Anal. Chem. 83: 4076–4084 [DOI] [PubMed] [Google Scholar]
  • 56.McEwen C. N., Pagnotti V. S., Inutan E. D., Trimpin S. 2010. New paradigm in ionization: multiply charged ion formation from a solid matrix without a laser or voltage. Anal. Chem. 82: 9164–9168 [DOI] [PubMed] [Google Scholar]
  • 57.Trimpin S.2011. Imaging mass spectrometry (MS) at atmospheric and intermediate pressure using LSI. 59th ASMS Conference on Mass Spectrometry and Allied Topics in Denver, Colorado. 2011.
  • 58.Li J., Inutan E. D., Wang B., Lietz C. B., Green D., Manly C. D., Richards A. L., Marshall D. D., Lingenfelter S., Ren Y., Trimpin S. 2012. Matrix assisted ionization: new aromatic and non-aromatic matrix compounds producing multiply charged lipid, peptide, and protein ions in the positive and negative mode observed directly from surfaces. J. Am. Soc. Mass Spectrom. DOI: 10. 1007/s13361-012-0413-z [DOI] [PubMed] [Google Scholar]
  • 59.Trimpin S., Wang B., Inutan E. D., Li J., Lietz C. B., Harron A., Pagnotti V. S., Sardelis D., McEwen C. N. 2012. A mechanism for ionization of nonvolatile compounds in mass spectrometry: considerations from MALDI and LSI. J. Am. Soc. Mass Spectrom. DOI: 10.1007/s13361-012-0414-y [DOI] [PubMed] [Google Scholar]
  • 60.Tanaka K., Waki H., Ido Y., Akita S., Yoshida Y., Yoshida T. 1988. Protein and polymer analyses up to m/z 100 000 by laser ionization time-of flight mass spectrometry. Rapid Commun. Mass Spectrom. 2: 151–153 [Google Scholar]
  • 61.Karas M., Hillenkamp F. 1988. Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Anal. Chem. 60: 2299–2301 [DOI] [PubMed] [Google Scholar]
  • 62.Krause J., Stoeckli M., Schlunegger U. P. 1996. Studies on the selection of new matrices for ultraviolet matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 10: 1927–1933 [DOI] [PubMed] [Google Scholar]
  • 63.Fitzgerald M. C., Parr G. R., Smith L. M. 1993. Basic matrixes for the matrix-assisted laser desorption/ionization mass spectrometry of proteins and oligonucleotides. Anal. Chem. 65: 3204–3211 [DOI] [PubMed] [Google Scholar]
  • 64.Trimpin S., Herath T. N., Inutan E. D., Cernat S. A., Wager-Miller J., Mackie K., Walker J. M. 2009. Field-free transmission geometry atmospheric pressure matrix-assisted laser desorption/ionization for rapid analysis of unadulterated tissue samples. Rapid Commun. Mass Spectrom. 23: 3023–3027 [DOI] [PubMed] [Google Scholar]
  • 65.Richards A. L., Lietz C. B., Wager-Miller J. B., Mackie K., Trimpin S. 2011. Imaging mass spectrometry in transmission geometry. Rapid Commun. Mass Spectrom. 25: 815–820 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Inutan E. D., Richards A. L., Wager-Miller J., Mackie K., McEwen C. N., Trimpin S. 2011. Laserspray ionization, a new method for protein analysis directly from tissue at atmospheric pressure with ultrahigh mass resolution and electron transfer dissociation. Mol. Cell. Proteomics. 10: 1–8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Trimpin S., Herath T. N., Inutan E. D., Wager-Miller J., Kowalski P., Claude E., Walker J. M., Mackie K. 2010. Automated solvent-free matrix deposition for tissue imaging by mass spectrometry. Anal. Chem. 82: 359–367 [DOI] [PubMed] [Google Scholar]
  • 68.Inutan E. D., Trimpin S. 2010. Laserspray ionization (LSI) ion mobility spectrometry (IMS) mass spectrometry (MS). J. Am. Soc. Mass Spectrom. 21: 1260–1264 [DOI] [PubMed] [Google Scholar]
  • 69.McEwen C. N., Trimpin S. 2011. An alternative ionization paradigm for atmospheric pressure mass spectrometry: flying elephants from Trojan horses. Int. J. Mass Spectrom. 300: 167–172 [Google Scholar]
  • 70.Richards A. L., Marshall D. D., Inutan E. D., McEwen C. N., Trimpin S. 2011. High-throughput analysis of peptides and proteins by laserspray ionization mass spectrometry. Rapid Commun. Mass Spectrom. 25: 247–250 [DOI] [PubMed] [Google Scholar]
  • 71.Lietz C. B., Richards A. L., Ren Y., Trimpin S. 2011. Inlet ionization: protein analyses from the solid state without the use of a voltage or a laser producing 67 charges on BSA, 66 kDa. Rapid Commun. Mass Spectrom. 25: 3453–3456 [DOI] [PubMed] [Google Scholar]
  • 72.McEwen C. N., Larsen B. S., Trimpin S. 2010. Laserspray ionization on a commercial atmospheric pressure-MALDI mass spectrometer ion source: selecting singly or multiply charged ions. Anal. Chem. 82: 4998–5001 [DOI] [PubMed] [Google Scholar]
  • 73. Ganglioside GQ1b tetrasodium salt (bovine brain): sc-203054. MSDS datasheet. Santa Cruz Biotechnology, Santa Cruz, CA. April 21, 2010.
  • 74.Domon B., Costello C. E. 1988. A systematic nomenclature for carbohydrate fragmentations in FAB-MS/MS spectra of glycoconjugates. Glycoconj. J. 5: 397–409 [Google Scholar]
  • 75.Ann Q., Adams J. 1992. Structural determination of ceramides and neutral glycosphingolipids by collisional activation of [M + Li]+ ions. J. Am. Soc. Mass Spectrom. 3: 260–263 [DOI] [PubMed] [Google Scholar]
  • 76.Li T., Ohashi Y., Nagai Y. 1995. Structural elucidation of underivatized gangliosides by electrospray-ionization tandem mass spectrometry (ESIMS/MS). Carbohydr. Res. 273: 27–40 [DOI] [PubMed] [Google Scholar]
  • 77.Tsui Z., Chen Q., Thomas M. J., Samuel M., Cui Z. 2005. A method for profiling gangliosides in animal tissues using electrospray ionization-tandem mass spectrometry. Anal. Biochem. 341: 251–258 [DOI] [PubMed] [Google Scholar]
  • 78.Jackson S. N., Wang H. Y., Woods A. S. 2007. In situ structural characterization of glycerophospholipids and sulfatides in brain tissue using MALDI-MS/MS. J. Am. Soc. Mass Spectrom. 18: 17–26 [DOI] [PubMed] [Google Scholar]
  • 79.Jackson S. N., Colsch B., Egan T., Lewis E. K., Schultz J. A., Woods A. S. 2011. Gangliosides’ analysis by MALDI-ion mobility MS. Analyst (Lond.). 136: 463–466 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Zarei M., Bindila L., Souady J., Dreisewerd K., Berkenkamp S., Müthing J., Peter-Katalinic´ J. 2008. A sialylation study of mouse brain gangliosides by MALDI a-TOF and o-TOF mass spectrometry. J. Mass Spectrom. 43: 716–725 [DOI] [PubMed] [Google Scholar]
  • 81.Alemeida R., Mosoarrca C., Chirita M., Udrescu V., Dinca N., Vukelic´ Ž., Allen M., Zamfir A. D. 2008. Coupling of fully automated chip-based electrospray ionization to high-capacity ion trap mass spectrometer for ganglioside analysis. Anal. Biochem. 378: 43–52 [DOI] [PubMed] [Google Scholar]
  • 82.Metelmann W., Vukelic´ Ž., Peter-Katalinic´ J. 2001. Nano-electrospray ionization time-of-flight mass spectrometry of gangliosides from human brain tissue. J. Mass Spectrom. 36: 21–29 [DOI] [PubMed] [Google Scholar]
  • 83.Merrill A. H., Jr., Sullards M. C., Allegood J. C., Kelly S., Wang E. 2005. Sphingolipidomics: high-throughput, structure-specific, and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrometry. Methods. 36: 207–224 [DOI] [PubMed] [Google Scholar]
  • 84.Taban I. M., Altelaar A. F., van der Burgt Y. E., McDonnell L. A., Heeren R. M. A., Fuchser J., Baykut G. 2007. Imaging of peptides in the rat brain using MALDI-FTICR mass spectrometry. J. Am. Soc. Mass Spectrom. 18: 145–151 [DOI] [PubMed] [Google Scholar]
  • 85.Smith D. F., Aizikov K., Duursma M. C., Giskes F., Spaanderman D-J., McDonnell L. A., O'Connor P. B., Heeren R. M. A. 2011. An external matrix-assisted laser desorption ionization source for flexible FT-ICR mass spectrometry imaging with internal calibration on adjacent samples. J. Am. Soc. Mass Spectrom. 22: 130–137 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Cornett D. S., Reyzer M. L., Chaurand P., Caprioli R. M. 2007. MALDI imaging mass spectrometry: molecular snapshots of biomolecular systems. Nat. Methods. 4: 828–833 [DOI] [PubMed] [Google Scholar]
  • 87.Grove K. J., Frappier S. L., Caprioli R. M. 2011. Matrix pre-coated MALDI MS targets for small molecule imaging in tissues. J. Am. Soc. Mass Spectrom. 22: 192–195 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Caprioli R. M., Farmer T., Gile J. 1997. Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS. Anal. Chem. 69: 4751–4760 [DOI] [PubMed] [Google Scholar]
  • 89.Altelaar A. F. M., Heeren R. M. A. 2009. Tissue analysis with high-resolution imaging mass spectrometry. Methods Mol. Biol. 492: 295–308 [DOI] [PubMed] [Google Scholar]
  • 90.Tang K., Page J. S., Marginean I., Kelly R. T., Smith R. D. 2011. Improving liquid chromatography-mass spectrometry sensitivity using a subambient pressure ionization with nanoelectrospray (SPIN) interface. J. Am. Soc. Mass Spectrom. 22: 1318–1325 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Wang B., Inutan E. D., Trimpin S. 2012. A new approach to high sensitivity liquid chromatography-mass spectrometry of peptides using nanoflow solvent-assisted inlet ionization. J. Am. Soc. Mass Spectrom. 23: 442–445 [DOI] [PubMed] [Google Scholar]
  • 92.Palmblad M., Wetterhall M., Markides K., Hakansson F., Bergquist J. 2000. Analysis of enzymatically digested peptide and protein mixtures using a 9.4 Tesla Fourier transform ion cyclotron mass spectrometer. Rapid Commun. Mass Spectrom. 14: 1029–1034 [DOI] [PubMed] [Google Scholar]
  • 93.Allen M. B. A.2009. Allen Institute for Brain Science, Seattle, WA. Accessed [month, day, year], at http://mouse.brain-map.org.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental Data

Articles from Journal of Lipid Research are provided here courtesy of American Society for Biochemistry and Molecular Biology

RESOURCES